SCNI

Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)

About Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Details

Daily high

$0.86

Daily low

$0.82

Price at open

$0.84

52 Week High

$6.18

52 Week Low

$0.61

Market cap

709,400

Dividend yield

0.00%

Volume

18,414

Avg. volume

62,466

P/E ratio

-.07

Scinai Immunotherapeutics Ltd. - American Depositary Shares News